Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/09/2008CA2321728C Epiallopregnanolone in the treatment of cns disorders
12/09/2008CA2321254C Pyradazine derivatives having inhibitory activity against interleukin-1.beta. production
12/09/2008CA2306486C Method and compositions for in situ formation of protective and/or medicated films on body tissue
12/09/2008CA2301017C Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
12/09/2008CA2294059C New amidino derivatives and their use as thrombin inhibitors
12/09/2008CA2286913C Composition and methods using an eutomer
12/09/2008CA2250188C Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
12/09/2008CA2217855C Tetralines
12/09/2008CA2183151C Host-vector system for use in gene therapy
12/04/2008WO2008148080A2 Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin]
12/04/2008WO2008148074A2 Inhibitors of mtor and methods of treatment using same
12/04/2008WO2008148064A1 Weight loss treatment
12/04/2008WO2008148034A1 Mapk/erk kinase inhibitors
12/04/2008WO2008148027A1 Antiparasitic combination and method for treating domestic animals
12/04/2008WO2008148016A1 Inhibiting the signs of aging by inhibiting nf-kappa b activation
12/04/2008WO2008148015A1 Sustained release formulation of melatonin
12/04/2008WO2008148008A1 High throughput bioassay for identifying selective trka receptor agonists, and gambogic amide, a selective trka agonist with neuroprotective activity
12/04/2008WO2008147962A1 Antiviral drugs for treatment or prevention of dengue infection
12/04/2008WO2008147956A2 Toll-like receptor 3 modulators and uses thereof
12/04/2008WO2008147952A1 Modulators of cystic fibrosis transmembrane conductance regulator
12/04/2008WO2008147945A1 Azacyclylbenzamide derivatives as histamine-3 antagonists
12/04/2008WO2008147939A1 Pharmaceutical compositions for the treatment of pain
12/04/2008WO2008147864A2 Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions
12/04/2008WO2008147856A1 Compositions useful for reducing nephrotoxicity and methods of use thereof
12/04/2008WO2008147831A1 Anthranilamides
12/04/2008WO2008147826A1 Malaria liver stage drugs
12/04/2008WO2008147822A1 Azaindazole compounds and methods of use
12/04/2008WO2008147817A2 Coated hyaluronic acid particles
12/04/2008WO2008147814A1 Pharmaceutical compositions and methods for preparing and using lipophilic organosulfur cell proliferation inhibitors
12/04/2008WO2008147807A2 Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal
12/04/2008WO2008147800A1 Pyrazolopyrrolidines as inhibitors of gamma secretase
12/04/2008WO2008147798A2 Edible composition comprising a slowly digestible or digestion resistant oligosaccharide composition
12/04/2008WO2008147797A2 Ion channel modulators and methods of use
12/04/2008WO2008147788A1 Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds
12/04/2008WO2008147786A1 ((bicylicheteroaryl) imidazolyl) methylheteroaryl compounds as adrenergic receptor agonists
12/04/2008WO2008147782A1 Raf inhibitors for the treatment of thyroid cancer
12/04/2008WO2008147764A1 Mmp inhibitors and methods of use thereof
12/04/2008WO2008147763A1 Mmp inhibitors and methods of use thereof
12/04/2008WO2008147715A2 Multi-dose concentrate esmolol with benzyl alcohol
12/04/2008WO2008147713A1 Wnt signaling inhibitors, and methods for making and using them
12/04/2008WO2008147697A1 Benzimidazolone chymase inhibitors
12/04/2008WO2008147687A1 Treating pancreatitis
12/04/2008WO2008147640A2 Hormone replacement therapy
12/04/2008WO2008147626A2 Thiazoles and pyrazoles useful as kinase inhibitors
12/04/2008WO2008147601A1 Methods and compositions for ameliorating thiazide induced hyperlipidemia
12/04/2008WO2008147562A2 Dietary formulations and methods for treatment of inflammation and other disorders
12/04/2008WO2008147557A2 Heteroaryl substituted thiazoles and their use as antiviral agents
12/04/2008WO2008147553A1 Tetracyclic inhibitors of fatty acid amide hydrolase
12/04/2008WO2008147551A1 Methods and compositions for stimulating cells
12/04/2008WO2008147547A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
12/04/2008WO2008147544A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
12/04/2008WO2008147540A1 S-triazine compounds, pharmaceutical compositions and methods of using the same
12/04/2008WO2008147518A1 Pyridyl piperidine orexin receptor antagonists
12/04/2008WO2008147483A2 Neurogenic compounds
12/04/2008WO2008147480A2 Hydroxamic acid derivatives of 3-phenyl propionic acids useful as thrapeutic agents for treating anthrax poisoning
12/04/2008WO2008147474A2 Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
12/04/2008WO2008147454A1 Selective inhibitors of translesion dna replication
12/04/2008WO2008147445A2 Use of 5,6-dimethylxanthenone-4-acetic acid as an antimicrobial agent
12/04/2008WO2008147417A1 Method of treating diabetes
12/04/2008WO2008147314A1 Spirocyclopropyl piperidine derivatives
12/04/2008WO2008147283A1 The use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplants
12/04/2008WO2008147245A2 Controlled release proxodolol pharmaceutical composition
12/04/2008WO2008147243A1 Binuclear nirtosyl-iron complexes with benzo-trans-heterocyclic derivatives and a method for the production thereof
12/04/2008WO2008147242A1 Use of a tetra-nitrosyl-iron complex with thiophenol as an antitumoral medicinal agent
12/04/2008WO2008147228A1 Treatment or prevention of bone conditions
12/04/2008WO2008147170A1 New process of synthesis for obtaining 5-methyl-1-phenyl-2 (ih) -pyridone, composition and use of the same
12/04/2008WO2008147169A2 Microemulsion containing pirfenidone
12/04/2008WO2008147168A1 Use of 5-methyl-1-phenyl-2-(1h)-pyridone for the treatment of the adverse effects of breast implants, such as inflammation, contraction of the capsule and fibrosis
12/04/2008WO2008147167A1 Pharmaceutical composition comprising the combinaton of the anti-microbial agent ciprofloxacin and the antioxidant agent ascorbic acid for the treatment of urinary infections
12/04/2008WO2008146989A1 A pharmaceutical composition containing daurinol for the prevention and treatment of cancers
12/04/2008WO2008146976A1 Anti-cancer medicine both for diagnosing and treating cancer
12/04/2008WO2008146919A1 Lincosamide derivative, and antibacterial agent comprising the same as active ingredient
12/04/2008WO2008146917A1 Lincomycin derivatives and antibacterial agents containing the same as the active ingredient
12/04/2008WO2008146914A1 Heterocyclic compound
12/04/2008WO2008146907A1 Oral composition
12/04/2008WO2008146883A1 Sleep-improving agent
12/04/2008WO2008146871A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity
12/04/2008WO2008146835A1 Composition for promoting equol production in the blood of subject unable to produce equol
12/04/2008WO2008146796A1 Medicated patch comprising 5-methyl-1-phenyl-2-(1h)-pyridone
12/04/2008WO2008146774A1 Tetrahydroisoquinolin-1-one derivative or salt thereof
12/04/2008WO2008146753A1 Therapeutic agent for cerebral infarction
12/04/2008WO2008146732A1 Infusion solution for peripheral intravenous administration
12/04/2008WO2008146731A1 Method for preparation of infusion solution for peripheral intravenous administration
12/04/2008WO2008146721A1 Prophylactic or therapeutic agent for age-related macular degeneration
12/04/2008WO2008146691A1 Pharmaceutical composition for prevention or treatment of hepatitis
12/04/2008WO2008146305A2 A pharmaceutical composition having virucidal and spermicidal activity
12/04/2008WO2008146284A2 Crystalline rotigotine base and preparation process therefor
12/04/2008WO2008146251A2 A primary micro rna expression cassette
12/04/2008WO2008146172A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/04/2008WO2008146156A2 An improved process for the preparation of aripiprazole
12/04/2008WO2008146105A1 Prostaglandin pharmaceutical compositions
12/04/2008WO2008146085A2 Inflammation and oxidative stress reducing composition for topical or oral administration
12/04/2008WO2008146064A1 New benzofuran derivatives as selective 5ht7 receptor inhibitors and process for their preparation
12/04/2008WO2008146063A1 New benzofuran derivatives as selective 5ht6 receptor inhibitors and process for their preparation
12/04/2008WO2008146036A1 Combination of checkponit kinase ( chk) and telangiectasia mutated (atm) inhibitors for the treatment of cancer
12/04/2008WO2008146035A1 Combination of chk and parp inhibitors for the treatment of cancers
12/04/2008WO2008146030A1 An antibacterial formulation comprising a dialkyl sulphosuccinate and a carbanilide antibacterial agent
12/04/2008WO2008146018A2 Drug delivery system comprising matrix metalloproteinase inhibitors
12/04/2008WO2008146008A1 Use of antivirals in the treatment of medical disorders
12/04/2008WO2008145996A2 Novel compounds and pharmaceutical preparations from neobeguea spec
1 ... 2963 2964 2965 2966 2967 2968 2969 2970 2971 2972 2973 2974 2975 2976 2977 2978 2979 2980 2981 2982 2983 ... 7860